In recognition of their outstanding contributions to the field of schizophrenia research, Cambridge Professors Barbara Sahakian and Trevor Robbins have been chosen to receive the Robert Sommer Award Medal, a high honour on behalf of the Robert Sommer Research Society. Winners are selected biennially by an international panel of judges, which awardees are invited to join after selection.
Professor Sahakian’s research within the University of Cambridge focuses on better understanding the brain in order to develop and improve pharmacological and psychological treatments for schizophrenia, as well as other disorders such as Alzheimer’s disease, while Professor Robbins works to understand the connections among brain systems and how these are related to psychiatric disorders.
They have been long-standing collaborators, and one of their main achievements was the development of the CANTAB battery. This series of cognitive tests recently celebrated its’ thirtieth anniversary and is used in clinical research and practice across the globe.
Congratulations to Professors Sahakian and Robbins!
This article is based on an earlier article written by Cambridge Neuroscience, where the nature of the award is also further elaborated upon.
Written by Anjalene Whittier and Hannah Jongsma.